| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | | Sold All | -55,895 | -100 % | | | | -2.00 % | $559 | | | | | | News Article | History of Timber Hill Llc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | | Sold All | -364 | -100 % | | | | -9.25 % | $18 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | | Sold All | -13,743 | -100 % | | | | -7.54 % | $550 | | | | | | News Article | History of Citadel L P Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 60,915 | Added More | 9,425 | 18.30 % | $32,285 | $29,848 | $-2,437 | -7.54 % | $-377 | | | | | | News Article | History of Northern Trust Corp Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 75,956 | Added More | 2,340 | 3.17 % | $40,257 | $37,218 | $-3,038 | -7.54 % | $-94 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 5,580 | Sold Some | -2,660 | -32.28 % | $2,957 | $2,734 | $-223 | -7.54 % | $106 | | | | | | News Article | History of Us Bancorp De Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 300 | No Change | 0 | 0 % | $147 | $147 | $0 | 0.00 % | $0 | | | | | | News Article | History of Barclays Plc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 46,867 | Added More | 28,882 | 160.58 % | $22,965 | $22,965 | $0 | 0.00 % | $0 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 5,000 | No Change | 0 | 0 % | $2,450 | $2,450 | $0 | 0.00 % | $0 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 1,342,200 | Added More | 40,900 | 3.14 % | $657,678 | $657,678 | $0 | 0.00 % | $0 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 222,016 | No Change | 0 | 0 % | $108,788 | $108,788 | $0 | 0.00 % | $0 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 125,000 | Sold Some | -495 | -0.39 % | $60,000 | $61,250 | $1,250 | 2.08 % | $-5 | | | | | | News Article | History of Bank Of America Corp Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 362,195 | No Change | 0 | 0 % | $173,854 | $177,476 | $3,622 | 2.08 % | $0 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 15,000 | New Holding | 15,000 | 100 % | $7,200 | $7,350 | $150 | 2.08 % | $150 | | | | | | News Article | History of Credit Suisse Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 330 | No Change | 0 | 0 % | $158 | $162 | $3 | 2.08 % | $0 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rbc Trustee Ltd | Institution | 2,000 | No Change | 0 | 0 % | $960 | $980 | $20 | 2.08 % | $0 | | | | | | News Article | History of Rbc Trustee Ltd Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -5,007 | -100 % | | | | 2.08 % | $-50 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 87,265 | Added More | 7,528 | 9.44 % | $40,142 | $42,760 | $2,618 | 6.52 % | $226 | | | | | | News Article | History of Ubs Ag Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | 1 | No Change | 0 | 0 % | $1 | $0 | $0 | -10.90 % | $0 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 7,000 | No Change | 0 | 0 % | $3,850 | $3,430 | $-420 | -10.90 % | $0 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 386,767 | Sold Some | -5,733 | -1.46 % | $204,987 | $189,516 | $-15,471 | -7.54 % | $229 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-10-29 | 2009-09-30 | 13F-HR | Wealthtrust Axiom Llc | Institution | 33,300 | Sold Some | -53,000 | -61.41 % | $17,649 | $16,317 | $-1,332 | -7.54 % | $2,120 | | | | | | News Article | History of Wealthtrust Axiom Llc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 2,300 | No Change | 0 | 0 % | $1,403 | $1,127 | $-276 | -19.67 % | $0 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-10-22 | 2009-09-30 | 13F-HR | S And T Bank | Institution | | Sold All | -500 | -100 % | | | | -19.67 % | $60 | | | | | | News Article | History of S And T Bank Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 37,272 | No Change | 0 | 0 % | $21,990 | $18,263 | $-3,727 | -16.94 % | $0 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 362,195 | No Change | 0 | 0 % | $224,561 | $177,476 | $-47,085 | -20.96 % | $0 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Hollis-Eden Pharmaceuticals |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 364 | No Change | 0 | 0 % | $193 | $178 | $-15 | -7.54 % | $0 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Hollis-Eden Pharmaceuticals |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |
RSS feed for HEPH